Literature DB >> 36268106

Optimal settings and clinical validation for automated Ki67 calculation in neuroendocrine tumors with open source informatics (QuPath).

Rima Pai1, Susan Karki2, Rakhee Agarwal3, Steven Sieber2, Samuel Barasch2.   

Abstract

Entities:  

Year:  2022        PMID： 36268106      PMCID： PMC9577125          DOI： 10.1016/j.jpi.2022.100141

Source DB:  PubMed          Journal:  J Pathol Inform


× No keyword cloud information.
  9 in total

1.  Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis.

Authors:  Maurice B Loughrey; Peter Bankhead; Helen G Coleman; Ryan S Hagan; Stephanie Craig; Amy M B McCorry; Ronan T Gray; Stephen McQuaid; Philip D Dunne; Peter W Hamilton; Jacqueline A James; Manuel Salto-Tellez
Journal:  Histopathology       Date:  2018-05-21       Impact factor: 5.087

2.  Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.

Authors:  Peter Bankhead; José A Fernández; Darragh G McArt; David P Boyle; Gerald Li; Maurice B Loughrey; Gareth W Irwin; D Paul Harkin; Jacqueline A James; Stephen McQuaid; Manuel Salto-Tellez; Peter W Hamilton
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

3.  Comparison of different anti-Ki67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis.

Authors:  Roisin Owens; Elaine Gilmore; Victoria Bingham; Christopher Cardwell; Hilary McBride; Stephen McQuaid; Matthew Humphries; Paul Kelly
Journal:  Histopathology       Date:  2020-09-02       Impact factor: 5.087

4.  Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.

Authors:  Balazs Acs; Vasiliki Pelekanou; Yalai Bai; Sandra Martinez-Morilla; Maria Toki; Samuel C Y Leung; Torsten O Nielsen; David L Rimm
Journal:  Lab Invest       Date:  2018-09-04       Impact factor: 5.662

5.  Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.

Authors:  Sarag A Boukhar; Matthew D Gosse; Andrew M Bellizzi; Anand Rajan K D
Journal:  Am J Clin Pathol       Date:  2021-09-08       Impact factor: 2.493

6.  A new tool for technical standardization of the Ki67 immunohistochemical assay.

Authors:  Thazin Nwe Aung; Balazs Acs; Jonathan Warrell; Yalai Bai; Patricia Gaule; Sandra Martinez-Morilla; Ioannis Vathiotis; Saba Shafi; Myrto Moutafi; Mark Gerstein; Benjamin Freiberg; Regan Fulton; David L Rimm
Journal:  Mod Pathol       Date:  2021-02-03       Impact factor: 7.842

7.  QuPath: Open source software for digital pathology image analysis.

Authors:  Peter Bankhead; Maurice B Loughrey; José A Fernández; Yvonne Dombrowski; Darragh G McArt; Philip D Dunne; Stephen McQuaid; Ronan T Gray; Liam J Murray; Helen G Coleman; Jacqueline A James; Manuel Salto-Tellez; Peter W Hamilton
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

8.  Ki67 Quantitative Interpretation: Insights using Image Analysis.

Authors:  Zoya Volynskaya; Ozgur Mete; Sara Pakbaz; Doaa Al-Ghamdi; Sylvia L Asa
Journal:  J Pathol Inform       Date:  2019-03-08

Review 9.  Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring.

Authors:  Claudio Luchini; Liron Pantanowitz; Volkan Adsay; Sylvia L Asa; Pietro Antonini; Ilaria Girolami; Nicola Veronese; Alessia Nottegar; Sara Cingarlini; Luca Landoni; Lodewijk A Brosens; Anna V Verschuur; Paola Mattiolo; Antonio Pea; Andrea Mafficini; Michele Milella; Muhammad K Niazi; Metin N Gurcan; Albino Eccher; Ian A Cree; Aldo Scarpa
Journal:  Mod Pathol       Date:  2022-03-05       Impact factor: 8.209
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.